New research is being presented at CROI 2014, the annual Conference on Retroviruses and Opportunistic Infections, from March 3 to 6, in Boston.
Conference Highlights
Relocating After an HIV Diagnosis
Mitigating Neuronal Injury in HIV
Combination Therapy May Eradicate HCV
Success With ED Opt-Out HIV Testing
News From the Meeting
Trial Bodes Well for Long-Acting HIV Drugs
Raltegravir Combo Gives New Anti-HIV Alternative
HIV Drug Linked to Low Bone Density in Babies
Researchers Report Treatment Clears HIV in Second Baby
Interventions to Reduce HIV Missing Some Drug Users
Long-Acting HIV Drug Eyed as Prevention
HIV Tx Tied to Low Infection From Sex
New Advances for HIV Prevention on the Horizon
HCV Drug Combo Has Near-Perfect Response Rate
All-Oral HCV Regimen Works in 9 Out of 10
HIV No Bar to HCV Therapy With New Agents
TB, HCV in Spotlight Along With HIV
More From the Meeting
